<?xml version="1.0" encoding="UTF-8"?>
<ref id="B305-viruses-12-00110">
 <label>305.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zou</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Umamoto</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kilani</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Trang</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells</article-title>
  <source>J. Biol. Chem.</source>
  <year>2003</year>
  <volume>278</volume>
  <fpage>37265</fpage>
  <lpage>37274</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M303531200</pub-id>
  <pub-id pub-id-type="pmid">12867424</pub-id>
 </element-citation>
</ref>
